January 20, 2025 - 08:17

Kareena Kapoor's cousin and actor Zahan Kapoor has shared reassuring news regarding Saif Ali Khan's health following his recent surgeries. In a statement, Zahan confirmed that Saif is now completely out of danger and is on the road to recovery. This update comes after a series of medical procedures that raised concerns among fans and family alike.
Zahan expressed relief, emphasizing that Saif's condition has improved significantly. He reassured everyone that the family is grateful for the support and concern shown by fans during this challenging time. The actor's resilience has been commendable, and he is expected to make a full recovery in the coming weeks.
As the family navigates this period, they remain hopeful and optimistic about Saif's health. Zahan's words provide comfort to many who have been following Saif's journey, highlighting the importance of family support during tough times. The Kapoor family looks forward to Saif's return to his normal routine soon.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...